delavirdine has been researched along with u 75875 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chong, KT; Pagano, PJ | 1 |
Chao, CC; Gekker, G; Hu, S; Peterson, PK | 1 |
2 other study(ies) available for delavirdine and u 75875
Article | Year |
---|---|
In vitro inhibition of human immunodeficiency virus type 1 by a combination of delavirdine (U-90152) with protease inhibitor U-75875 or interferon-alpha.
Topics: Antiviral Agents; CD4-Positive T-Lymphocytes; Cell Line; Cell Survival; Cells, Cultured; Delavirdine; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; HIV Protease Inhibitors; HIV Reverse Transcriptase; HIV-1; Humans; Indoles; Interferon Type I; Leukocytes, Mononuclear; Microbial Sensitivity Tests; Oligopeptides; Piperazines; Recombinant Proteins; Reverse Transcriptase Inhibitors; Virus Replication | 1995 |
Anti-human immunodeficiency virus type 1 activities of U-90152 and U-75875 in human brain cell cultures.
Topics: Antiviral Agents; Brain; Cells, Cultured; Delavirdine; HIV Protease Inhibitors; HIV-1; Humans; Indoles; Oligopeptides; Piperazines; Reverse Transcriptase Inhibitors; Tumor Necrosis Factor-alpha | 1994 |